ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xagrid 0,5 mg, Hartkapseln - 100 Kapsel(n)
54720068 Takeda Pharma AG
Xagrid 0,5 mg, Hartkapseln08.12.1999
  08.12.1999
Anagrelide (L01XX35)20.12.2004
WHO-DDD 
07.16.40.100 Kapsel(n)
07.16.40. 
B  
Yes 
IPCI
207.67No
    
10 %240.45
  
7680547200687Synthetika
2353168 
Composition
anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, povidonum K 30, lactosum 65.76 mg, lactosum monohydricum 53.74 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Anagrelide0.5 mg
BAG: Active AgentDose
Anagrelide0.5 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Ammoniae Solutio Concentrata  
Cellulosum Microcristallinum  
Crospovidonum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Lactosum65.76 mg 
Lactose Monohydrate53.74 mg 
Magnesii Stearas  
Povidonum K30  
Pro Capsula  
Propylenglycol  
 
Source
Data was imported : 06.10.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home